The pilot programme Molecular Libraries Initiative, part of the NIH Roadmap, gave academic researchers access to high-throughput screening technology and expertise. Now, as this initiative enters its next phase, a key question is how to make the most of the data generated. David Bradley investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Dealing with a data dilemma. Nat Rev Drug Discov 7, 632–633 (2008). https://doi.org/10.1038/nrd2649
Issue Date:
DOI: https://doi.org/10.1038/nrd2649